Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Hydrocarbon Inhalation Injury Clinical Presentation

  • Author: Rakesh Vadde, MBBS; Chief Editor: Michael R Bye, MD  more...
 
Updated: Apr 18, 2014
 

History

A high index of suspicion is required because exposure to most volatile substances is not detectible by physical examination and because people who intentionally abuse inhalants initially deny hydrocarbon inhalation. Presentation of a patient with a characteristic odor of gasoline or kerosene likely suggests exposure; however, patients who present with altered mental status or intoxication should be scrutinized for the possibility of inhalation abuse in addition to abuse of other common drugs.

Populations at higher risk should be questioned more carefully; high-risk populations include children and adolescents from families of low socioeconomic status, in whom unemployment and poverty rates are high, as well as those lacking adult supervision.

Common symptoms between episodes of abuse include poor social functioning, underachievement at work or school, apathy, chest pain, and thirst.

Carefully investigate the possibility of illicit solvent inhalation in all patients presenting with the following unexplained symptoms or factors:

  • Altered mental status, cerebellar dysfunction, peripheral neuropathy
  • Behavioral changes, deteriorating school performance
  • Pulmonary hypertension with or without cor pulmonale
  • Acute rhabdomyolysis
  • Renal tubular acidosis with severe hypokalemia and hypophosphatemia
  • GI symptoms, such as abdominal pain, hematemesis, nausea, and vomiting
  • Mothers of infants with toluene embryopathy
  • Evaluate all patients who present after autoerotic asphyxiation for solvent abuse because such chemicals may be used to relax inhibitions.

When inhalant abuse is identified, make efforts to specifically identify the toxins involved because abusers often ingest various solvent-inhalants and frequently misidentify the substances involved. Hydrocarbons are not often part of a routine toxicology screen; therefore, if such an exposure is clinically suspected, the laboratory must be alerted and specific identifying tests must be obtained.

Next

Physical

Patients who have acute decompensation from solvent-inhalant abuse are frequently found near the offending agent; however, many patients who present to medical care have no obvious physical findings to suggest hydrocarbon exposure or inhalant abuse. Some patients may present with subtle signs of abuse, such as paint staining around the mouth or nose. A characteristic odor may be detectable on presentation because a significant proportion of the absorbed chemical exits the body via the lungs. Also, the product may have been spilled onto clothing during use.

Evidence of chronic inhalant abuse may be more subtle. Patients presenting with unexplained peripheral neuropathy and weakness, diffuse GI symptoms, or neuropsychiatric symptoms should raise suspicion of chronic solvent-inhalant abuse. Electrolyte abnormalities, including hypokalemia, hypophosphatemia, and acidosis, should further raise suspicion. However, the nature of these symptoms is not diagnostic of solvent-inhalant abuse; therefore, a very broad differential diagnosis is required.

Signs and symptoms

A single, loud S2 may be evident as a result of pulmonary hypertension. Ventricular arrhythmias or bradycardia may be observed. Discolored urine may be evident from rhabdomyolysis.

Adolescents who present with unexplained obtundation or seizures should be examined carefully for evidence of recent solvent-inhalant exposure. Physical findings of recent solvent-inhalant abuse include flecks of paint around the nose and mouth and staining of the fingers, nails, and clothing.

A solvent aroma may be present on the breath. Rhinitis, nasal mucosal erosions, epistaxis, hoarse voice, and conjunctivitis may result from local exposure.

The acute neurologic effects of inhaled solvents generally wear off within minutes to a few hours, but the effects of more chronic use may persist.

Muscle weakness, diffuse GI symptoms, and neuropsychiatric symptoms are 3 major symptom patterns of chronic abuse.

Previous
Next

Causes

The common idea that solvent inhalation is innocuous undoubtedly contributes to solvent-inhalant abuse. The wide availability of organic solvents in commonly used household products makes them readily accessible.

Commonly abused products include the following:

  • Liquids - Model glue, gasoline, contact cement (rubber cement), lacquers, nail-polish remover, dry-cleaning fluids
  • Aerosols - Spray paints, butane fuel, lighter fluid, cooking sprays, cosmetics, hairspray, toiletries, deodorants

Chemicals found in abused inhalants include the following:

  • Propane
  • Butane
  • n-Hexane
  • Trichloroethylene
  • Freon
  • Benzene
  • Toluene
  • Xylene
  • Acetone
  • Methyl isobutyl ketone
Previous
 
 
Contributor Information and Disclosures
Author

Rakesh Vadde, MBBS Fellow in Pulmonary Medicine, Interfaith Medical Center

Rakesh Vadde, MBBS is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, American Thoracic Society

Disclosure: Nothing to disclose.

Coauthor(s)

M Frances J Schmidt, MD Chief of Pulmonary Medicine, Pulmonary Fellowship Program, Teaching Attending Physician, Department of Medicine, Interfaith Medical Center

M Frances J Schmidt, MD is a member of the following medical societies: American College of Chest Physicians, American College of Physicians

Disclosure: Nothing to disclose.

Divya Salhan, MD Resident Physician, Department of Internal Medicine, Interfaith Medical Center

Disclosure: Nothing to disclose.

Specialty Editor Board

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Charles Callahan, DO Professor, Chief, Department of Pediatrics and Pediatric Pulmonology, Tripler Army Medical Center

Charles Callahan, DO is a member of the following medical societies: American Academy of Pediatrics, American College of Chest Physicians, American College of Osteopathic Pediatricians, American Thoracic Society, Association of Military Surgeons of the US, Christian Medical and Dental Associations

Disclosure: Nothing to disclose.

Chief Editor

Michael R Bye, MD Professor of Clinical Pediatrics, State University of New York at Buffalo School of Medicine; Attending Physician, Pediatric Pulmonary Division, Women's and Children's Hospital of Buffalo

Michael R Bye, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Chest Physicians, American Thoracic Society

Disclosure: Nothing to disclose.

Additional Contributors

Girish D Sharma, MD, FCCP, FAAP Professor of Pediatrics, Rush Medical College; Director, Section of Pediatric Pulmonology and Rush Cystic Fibrosis Center, Rush Children's Hospital, Rush University Medical Center

Girish D Sharma, MD, FCCP, FAAP is a member of the following medical societies: American Academy of Pediatrics, American College of Chest Physicians, American Thoracic Society, Royal College of Physicians of Ireland

Disclosure: Nothing to disclose.

Acknowledgements

Heidi Connolly, MD Associate Professor of Pediatrics and Psychiatry, University of Rochester School of Medicine and Dentistry; Director, Pediatric Sleep Medicine Services, Strong Sleep Disorders Center

Heidi Connolly, MD is a member of the following medical societies: American Academy of Pediatrics, American Thoracic Society, and Society of Critical Care Medicine

Disclosure: Nothing to disclose.

Jason M Kane, MD, FAAP Assistant Professor of Pediatrics, Northwestern University Feinberg School of Medicine; Attending Physician, Department of Pediatrics, Section of Pediatric Critical Care and Cardiac Intensive Care, Children's Memorial Hospital

Jason M Kane, MD, FAAP is a member of the following medical societies: American Academy of Pediatrics, American College of Chest Physicians, American Thoracic Society, and Society of Critical Care Medicine

Disclosure: Nothing to disclose.

Emily B Nazarian, MD Assistant Professor of Pediatrics, Fellowship Director, Pediatric Critical Care, Golisano Children's Hospital at Strong

Emily B Nazarian, MD is a member of the following medical societies: American Academy of Pediatrics

Disclosure: Nothing to disclose.

References
  1. McHugh MJ. The abuse of volatile substances. Pediatr Clin North Am. 1987 Apr. 34(2):333-40. [Medline].

  2. Phatak DR, Walterscheid J. Huffing air conditioner fluid: a cool way to die?. Am J Forensic Med Pathol. 2012 Mar. 33(1):64-7. [Medline].

  3. US Consumer Product Safety Commisson. CPSC Requires Child-Resistant Packaging for Common Household Products Containing Hydrocarbons, Including Some Baby Oils. Available at http://www.cpsc.gov/en/Newsroom/News-Releases/2002/CPSC-Requires-Child-Resistant-Packaging-for-Common-Household-Products-Containing-Hydrocarbons-Including-Some-Baby-Oils/. Accessed: April 11, 2014.

  4. Mahmoodpoor A, Soleimanpour H, Hamishehkar H. Multi organ failure following intravenous gasoline for suicide: a case report. Acta Med Iran. 2012. 50(12):846-8. [Medline].

  5. Lyon RC, McComb JA, Schreurs J, et al. A relationship between alcohol intoxication and the disordering of brain membranes by a series of short-chain alcohols. J Pharmacol Exp Ther. 1981 Sep. 218(3):669-75. [Medline].

  6. Jones HE, Balster RL. Inhalant abuse in pregnancy. Obstet Gynecol Clin North Am. 1998 Mar. 25(1):153-67. [Medline].

  7. Bass M. Sudden sniffing death. JAMA. 1970 Jun 22. 212(12):2075-9. [Medline].

  8. LoVecchio F, Fulton SE. Ventricular fibrillation following inhalation of Glade Air Freshener. Eur J Emerg Med. 2001 Jun. 8(2):153-4. [Medline].

  9. Edwards KE, Wenstone R. Successful resuscitation from recurrent ventricular fibrillation secondary to butane inhalation. Br J Anaesth. 2000 Jun. 84(6):803-5. [Medline].

  10. El-Menyar AA, El-Tawil M, Al Suwaidi J. A teenager with angiographically normal epicardial coronary arteries and acute myocardial infarction after butane inhalation. Eur J Emerg Med. 2005 Jun. 12(3):137-41. [Medline].

  11. Berkowitz FE, Booth WR. Glue-sniffing in a young child. S Afr Med J. 1978 Oct 7. 54(15):622. [Medline].

  12. Anderson CE, Loomis GA. Recognition and prevention of inhalant abuse. Am Fam Physician. 2003 Sep 1. 68(5):869-74. [Medline].

  13. King GS, Smialek JE, Troutman WG. Sudden death in adolescents resulting from the inhalation of typewriter correction fluid. JAMA. 1985 Mar 15. 253(11):1604-6. [Medline].

  14. Frangides CY, Tzortzatos GV, Koulouras V, et al. Acute massive rhabdomyolysis due to prolonged inhalation of liquid gas. Eur J Emerg Med. 2003 Mar. 10(1):44-6. [Medline].

  15. Harris D, Mirza Z. Butane encephalopathy. Emerg Med J. 2005 Sep. 22(9):676-7. [Medline].

  16. Kuspis DA, Krenzelok EP. Oral frostbite injury from intentional abuse of a fluorinated hydrocarbon. J Toxicol Clin Toxicol. 1999. 37(7):873-5. [Medline].

  17. Streicher HZ, Gabow PA, Moss AH, et al. Syndromes of toluene sniffing in adults. Ann Intern Med. 1981 Jun. 94(6):758-62. [Medline].

  18. Arnold GL, Kirby RS, Langendoerfer S, et al. Toluene embryopathy: clinical delineation and developmental follow-up. Pediatrics. 1994 Feb. 93(2):216-20. [Medline].

  19. Pearson MA, Hoyme HE, Seaver LH, et al. Toluene embryopathy: delineation of the phenotype and comparison with fetal alcohol syndrome. Pediatrics. 1994 Feb. 93(2):211-5. [Medline].

  20. Devathasan G, Low D, Teoh PC, et al. Complications of chronic glue (toluene) abuse in adolescents. Aust N Z J Med. 1984 Feb. 14(1):39-43. [Medline].

  21. Aydin K, Sencer S, Demir T, et al. Cranial MR findings in chronic toluene abuse by inhalation. AJNR Am J Neuroradiol. 2002 Aug. 23(7):1173-9. [Medline].

  22. Borne J, Riascos R, Cuellar H, et al. Neuroimaging in drug and substance abuse part II: opioids and solvents. Top Magn Reson Imaging. 2005 Jun. 16(3):239-45. [Medline].

  23. Rauber-Luthy C, Kupferschmidt H. Household chemicals: management of intoxication and antidotes. EXS. 2010. 100:339-63. [Medline].

  24. Weibrecht KW, Rhyee SH. Acute respiratory distress associated with inhaled hydrocarbon. Am J Ind Med. 2011 Dec. 54(12):911-4. [Medline].

  25. Lorenc JD. Inhalant abuse in the pediatric population: a persistent challenge. Curr Opin Pediatr. 2003 Apr. 15(2):204-9. [Medline].

  26. Kurtzman TL, Otsuka KN, Wahl RA. Inhalant abuse by adolescents. J Adolesc Health. 2001 Mar. 28(3):170-80. [Medline].

  27. Wu LT, Pilowsky DJ, Schlenger WE. Inhalant abuse and dependence among adolescents in the United States. J Am Acad Child Adolesc Psychiatry. 2004 Oct. 43(10):1206-14. [Medline].

  28. Driscoll DL, Dotterrer B, Collins D, Ogilvie K, Grube J, Johnson K. Demographic and contextual factors associated with inhalant use among youth in rural Alaska. Int J Circumpolar Health. 2012 Apr 16. 71:1-4. [Medline]. [Full Text].

  29. Uzun N, Kendirli Y. Clinical, socio-demographic, neurophysiological and neuropsychiatric evaluation of children with volatile substance addiction. Child Care Health Dev. 2005 Jul. 31(4):425-32. [Medline].

  30. Dinwiddie SH. Abuse of inhalants: a review. Addiction. 1994 Aug. 89(8):925-39. [Medline].

  31. National Institute of Drug Abuse. DrugFacts: Inhalants. Available at http://www.drugabuse.gov/sites/default/files/dfinhalants_1.pdf. Accessed: April 11, 2014.

  32. Ashton CH. Solvent abuse. BMJ. 1990 Jan 20. 300(6718):135-6. [Medline].

  33. Anderson HR, Macnair RS, Ramsey JD. Deaths from abuse of volatile substances: a national epidemiological study. Br Med J (Clin Res Ed). 1985 Jan 26. 290(6464):304-7. [Medline].

  34. Lowenstein LF. Recent research into glue-sniffing--extent of the problem its repercussions and treatment approaches. Int J Soc Psychiatry. 1985 Summer. 31(2):93-7. [Medline].

  35. Baird CA, Furek MW. Adolescents and inhalant abuse: how huffing affects the myelin sheath. J Addict Nurs. 2012 May. 23(2):129-31. [Medline].

  36. Westermeyer J. The psychiatrist and solvent-inhalant abuse: recognition, assessment, and treatment. Am J Psychiatry. 1987 Jul. 144(7):903-7. [Medline].

  37. Padilla ER, Padilla AM, Morales A, et al. Inhalant, marijuana, and alcohol abuse among barrio children and adolescents. Int J Addict. 1979 Oct. 14(7):945-64. [Medline].

  38. Broussard LA. The role of the laboratory in detecting inhalant abuse. Clin Lab Sci. 2000 Fall. 13(4):205-9. [Medline].

  39. Blanchard EB, Libet JM, Young LD. Apneic aversion and covert sensitization in the treatment of a hydrocarbon inhalation addiction: A case study. J Behav Ther Experimental Psych. December 1973. 4:383–87.

  40. Baydala L. Inhalant abuse. Paediatr Child Health. 2010 Sep. 15(7):443-54. [Medline]. [Full Text].

 
Previous
Next
 
Anteroposterior view of the chest of 14-month-old boy 30 hours after ingesting lamp oil. Note the central right lower lobe infiltrate obscuring the right heart border.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.